Fibromyalgia Clinical Trial
Official title:
A 15 Week, Randomized, Double Blind, Parallel-group, Placebo-controlled, Flexible-dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
Verified date | June 2015 |
Source | Pfizer |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will compare pregabalin with placebo over a 15 week period in adolescents with fibromyalgia aged 12-17 years to evaluate the safety and efficacy of pregabalin.
Status | Completed |
Enrollment | 107 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 17 Years |
Eligibility | Inclusion Criteria: - Diagnosis of fibromyalgia - 12-17 years of age Exclusion Criteria: - Patients with other pain conditions - Previous treatment with pregabalin - Patients taking excluded medication |
Country | Name | City | State |
---|---|---|---|
Czechia | Bioregeneracni a rehabilitacni centrum | Ricany | |
India | Department of Physical Medicine & Rehabilitation | Lucknow | Uttar Pradesh |
India | Mallikatta Neuro Centre | Mangalore | Karnataka |
India | Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopaedics | Nagpur | Maharashtra |
India | Krishna Institute of Medical Sciences Ltd | Secunderabad | Andhra Pradesh |
Taiwan | National Taiwan University Hospital | Taipei | |
United States | Akron Children's Hospital | Akron | Ohio |
United States | Akron Children's Hospital | Boardman | Ohio |
United States | Boardman Medical Pavilion | Boardman | Ohio |
United States | Medical University of South Carolina | Charleston | South Carolina |
United States | Medical University of South Carolina, Pediatric Rheumatology | Charleston | South Carolina |
United States | MUSC University Children's Hospital | Charleston | South Carolina |
United States | University of Cincinnati | Cincinnati | Ohio |
United States | Medical Research & Health Education Foundation, Inc. | Columbus | Georgia |
United States | Nationwide Children's Hospital | Columbus | Ohio |
United States | The Research Institute at Nationwide Children's Hospital | Columbus | Ohio |
United States | Arthritis Associates of South Florida | Delray Beach | Florida |
United States | Delray Research Associates | Delray Beach | Florida |
United States | Eileen Messing, Psy D. | Delray Beach | Florida |
United States | Duke University Medical Center | Durham | North Carolina |
United States | North Georgia Rheumatology, PC | Lawrenceville | Georgia |
United States | Childrens Hospital Los Angeles | Los Angeles | California |
United States | Kosair Charities Pediatric Clinical Research Unit | Louisville | Kentucky |
United States | Kosair Children's Hospital | Louisville | Kentucky |
United States | University of Louisville | Louisville | Kentucky |
United States | University Pediatric Rheumatology of Kentucky, LLC | Louisville | Kentucky |
United States | Florida Medical Center and Research, Inc. | Miami | Florida |
United States | Carolina Research Center | Myrtle Beach | South Carolina |
United States | Harmony Clinical Research, Incorporated | North Miami Beach | Florida |
United States | Rheumatology Associates of Central Florida, PA | Orlando | Florida |
United States | St. Christopher's Hospital for Children / Section of Rheumatology | Philadelphia | Pennsylvania |
United States | Duke Medicine Plaza | Raleigh | North Carolina |
United States | A&A Pain Institute of St. Louis | Saint Louis | Missouri |
United States | Fatigue Consultation Clinic | Salt Lake City | Utah |
United States | Apex Research Institute | Santa Ana | California |
United States | University of Massachusetts Memorial Medical Center Department of Pediatrics | Worcester | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
United States, Czechia, India, Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change From Baseline to Week 15 in Mean Pain Diary Score | The Primary Endpoint is based on the daily pain diary, and is defined as change from baseline to Week 15 in mean pain diary score. The daily pain diary consists of an 11-point numeric rating scale ranging from zero (no pain) to 10 (worst possible pain). The patients rate their pain during the past 24 hours by choosing the appropriate number between 0 ("no pain") and 10 ("worst possible pain"). | Week 15 | |
Secondary | Change From Baseline to Week 15 in Mean Sleep Quality Diary Score | Change from Baseline to endpoint in mean sleep quality score from the daily sleep diary, defined as the mean of the last 7 diary entries prior to Visit 10 in the study while the participant is on study medication. The daily quality of sleep diary consists of an 11-point numeric rating scale with which the patient rates the quality of their sleep during the past 24 hours. Zero indicates "best possible sleep" and 10 indicates "worst possible sleep". | Week 15 | |
Secondary | Mean Change From Baseline to Weekly Mean Pain Score - Daily Pain Numeric Rating Scale (NRS) | Mean pain score was calculated for each week during the double-blind treatment phase (Week 1 to Week 15). For each week, only days up to the last day on study medication were considered. A minimum of 4 pain diaries were required to calculate the mean pain score. The pain NRS consists of an 11 point NRS ranging from 0 (no pain) to 10 (worst possible pain). | Baseline to Week 15 | |
Secondary | Mean Change From Baseline to Weekly Mean Sleep Quality Score (NRS) | Mean sleep quality score was calculated for each week during the double-blind treatment phase (Week 1 to Week 15). A minimum of 4 sleep diaries are required to calculate the mean pain score. The daily quality of sleep diary consists of an 11-point numeric rating scale with which the patient rates the quality of their sleep during the past 24 hours. Zero indicates "best possible sleep" and 10 indicates "worst possible sleep". | Baseline to Week 15 | |
Secondary | Change From Baseline to Week 15 in Mean Pain Numeric Rating Scale (1 Week Recall Period) | The weekly pain numeric rating scale (Weekly Pain NRS) consists of an 11-point NRS ranging from 0 (no pain) to 10 (worst possible pain), where higher scores indicate greater degree of impairment. Participants choose the number that best describes the pain during the last week. | Week 15 | |
Secondary | Proportion of 30% Responders in Weekly Mean Pain Score (NRS) at Week 15 | At each visit, participants with at least 30% reduction from Baseline in mean pain score were defined as a 30% responder at the visit. The pain NRS consists of an 11 point NRS ranging from 0 (no pain) to 10 (worst possible pain). | Week 15 | |
Secondary | Proportion of 50% Responder in Weekly Mean Pain Score (NRS) at Week 15 | At each visit, participants with at least 50% reduction from Baseline in mean pain score were defined as a 50% responder at the visit. The pain NRS consists of an 11 point NRS ranging from 0 (no pain) to 10 (worst possible pain). | Week 15 | |
Secondary | Proportion of Patient Global Impression Change (PGIC) at Week 15 | Responder rates based on PGIC was derived and tabulated by treatment group. A responder was defined as a participant who reports much improved or very much improved. The PGIC is a patient-rated single item that measures patient's perception of change in their overall status since starting study medication on a scale ranging from 1 (very much improved) to 7 (very much worse). | Week 15 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05659862 -
Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT03042728 -
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
|
N/A | |
Recruiting |
NCT06097091 -
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
|
N/A | |
Recruiting |
NCT04554784 -
Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT03300635 -
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
|
N/A | |
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT03166995 -
Postural Exercises in Women With Fibromyalgia
|
N/A | |
Completed |
NCT03227952 -
Sensory Stimulation in Fibromyalgia
|
N/A | |
Recruiting |
NCT06237595 -
Vagus Nerve Stimulation in Fibromyalgia
|
N/A | |
Completed |
NCT01888640 -
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
|
N/A | |
Completed |
NCT03641495 -
Pain Education and Therapeutic Exercise for Fibromyalgia
|
N/A | |
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Active, not recruiting |
NCT05128162 -
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
|
Phase 2 | |
Completed |
NCT04674878 -
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Completed |
NCT03129906 -
Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients
|
N/A | |
Completed |
NCT05058911 -
Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
|
N/A | |
Recruiting |
NCT04571853 -
New Educational Tool for FM
|
N/A | |
Recruiting |
NCT04571528 -
Effectiveness of VIRTUAL FIBROWALK STUDY
|
N/A |